{"groups":[{"description":"Donors receive filgrastim subcutaneously (SC) and plerixafor SC on day -14 and undergo leukapheresis to collect peripheral blood stem cells (PBSC) on day -13. These cells are frozen to preserve them. Treatment modifications may apply according to sufficient collection of PBSC. Patients receive standard high-dose conditioning and undergo allogeneic PBSC transplantation on day 0 using the previously frozen cells.\n\nAfter completion of study treatment, donors are followed up 1 day after the last stem cell donation.\n\nplerixafor: Given SC\n\nfilgrastim: Given SC\n\nperipheral blood stem cell transplantation: Infusion of peripheral blood stem cells\n\nallogeneic hematopoietic stem cell transplantation: Infusion of hematopoietic stem cells","id":"FG000","title":"Filgrastim and Plerixafor for PBSC Mobilization"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}